Global /China /Healthcare /Drug Manufacturers - General /301277

Newland Pharmaceutical Co., Ltd.

301277

• SHE: 301277 • Delayed

11.53CNY 0%

1.70 USD

As of 24 June 2026, Newland Pharmaceutical Co., Ltd. has a market cap of $667.28M USD, ranking #13217 globally and #4001 in China. It ranks #1197 in the Healthcare sector, and #443 in the Drug Manufacturers - General industry.

Global Rank

13217

Country Rank

4001

Sector Rank

1197

Industry Rank

443

Key Stats

Market Cap

$667.28MUSD

4.52B CNY

Enterprise Value

$569.55MUSD

3.86B CNY

Revenue (TTM)

$97.35MUSD

659.54M CNY

EBITDA (TTM)

$23.08MUSD

156.25M CNY

Net Income (TTM)

$14.88MUSD

100.78M CNY

EBITDA Margin

24%

Profit Margin

15%

PE Ratio

44.7

PS Ratio

6.9

PB Ratio

2.8

EV/EBITDA

24.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Luwei Zhang open_in_new

Employees

981

Founded

2005

Website

newlandpharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-1.7%	-1.8%	-8.1%	-12%	-2.2%	-2.4%	4.8%	-45%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301277 河南新天地药业股份有限公司 Class A ISIN: CNE1000065K2 Shares Out.: Shares Outstanding: 392.078M¹ Shares Float: 376.103M² TV: TradingView: SZSE: 301277 SA: Stock Analysis: SHE: 301277 YF: Yahoo Finance: 301277.SZ GF: Google Finance: SHE: 301277 BA: Barron's: 301277 MS: Morningstar: XSHE: 301277	11.53 CNY	TV: TradingView: SZSE: 301277 SA: Stock Analysis: SHE: 301277 YF: Yahoo Finance: 301277.SZ GF: Google Finance: SHE: 301277 BA: Barron's: 301277 MS: Morningstar: XSHE: 301277

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Newland Pharmaceutical Co., Ltd.

Newland Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical intermediates and APIs in China. The company offers pharmaceutical intermediates, including L-4-hydroxyphenylglycine methyl ester, L-hydroxyphenylglycine potassium salt, L-4-hydroxyphenylglycine, and p-Toluenesulfonic acid. It also provides APIs, such as ropivacaine hydrochloride, naphazoline hydrochloride, moxifloxacin hydrochloride, lidocaine hydrochloride, vildagliptin, tadalafil, chlorpheniramine maleate, clopidogrel bisulfate, lidocaine, gatifloxacin, febuxostat, esomeprazole sodium, and esomeprazole magnesium. The company was formerly known as Henan Newland Pharmaceutical Co., Ltd. and changed its name to Newland Pharmaceutical Co., Ltd. in June 2023. Newland Pharmaceutical Co., Ltd. was founded in 2005 and is based in Changge, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.86B 364.89B CNY 8K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.65B 336.36B CNY 7K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.51B 223.48B HKD 4K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.79B 147.32B HKD 3K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.0B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 114K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 82K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 54K%	97.4	United States
Roche Holding AG SIX: RO	$316.71B 256.25B CHF 47K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$285.49B 215.59B GBP 43K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 41K%	15.1	United States

chevron_leftBack